KR20150010932A - 카바페넴의 무세포 제조법 - Google Patents

카바페넴의 무세포 제조법 Download PDF

Info

Publication number
KR20150010932A
KR20150010932A KR1020147009054A KR20147009054A KR20150010932A KR 20150010932 A KR20150010932 A KR 20150010932A KR 1020147009054 A KR1020147009054 A KR 1020147009054A KR 20147009054 A KR20147009054 A KR 20147009054A KR 20150010932 A KR20150010932 A KR 20150010932A
Authority
KR
South Korea
Prior art keywords
optionally substituted
compound
formula
salt
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020147009054A
Other languages
English (en)
Korean (ko)
Inventor
윌리엄 제러미 블레이크
다니엘 클레인-마커스차머
Original Assignee
그린라이트 바이오사이언시스, 아이엔씨.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 그린라이트 바이오사이언시스, 아이엔씨. filed Critical 그린라이트 바이오사이언시스, 아이엔씨.
Publication of KR20150010932A publication Critical patent/KR20150010932A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • C12P17/184—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system containing a beta-lactam ring, e.g. thienamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0008—Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0026—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1217—Phosphotransferases with a carboxyl group as acceptor (2.7.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y102/00—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
    • C12Y102/01—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with NAD+ or NADP+ as acceptor (1.2.1)
    • C12Y102/01041—Glutamate-5-semialdehyde dehydrogenase (1.2.1.41)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y105/00—Oxidoreductases acting on the CH-NH group of donors (1.5)
    • C12Y105/99—Oxidoreductases acting on the CH-NH group of donors (1.5) with other acceptors (1.5.99)
    • C12Y105/99008—Proline dehydrogenase (1.5.99.8)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y203/00—Acyltransferases (2.3)
    • C12Y203/01—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/02—Phosphotransferases with a carboxy group as acceptor (2.7.2)
    • C12Y207/02011—Glutamate 5-kinase (2.7.2.11)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y603/00—Ligases forming carbon-nitrogen bonds (6.3)
    • C12Y603/03—Cyclo-ligases (6.3.3)
    • C12Y603/03004—(Carboxyethyl)arginine beta-lactam-synthase (6.3.3.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y603/00—Ligases forming carbon-nitrogen bonds (6.3)
    • C12Y603/04—Other carbon-nitrogen ligases (6.3.4)
    • C12Y603/04016—Carbamoyl-phosphate synthase (ammonia) (6.3.4.16)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y603/00—Ligases forming carbon-nitrogen bonds (6.3)
    • C12Y603/05—Carbon-nitrogen ligases with glutamine as amido-N-donor (6.3.5)
    • C12Y603/05005—Carbamoyl-phosphate synthase (glutamine-hydrolysing) (6.3.5.5)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Enzymes And Modification Thereof (AREA)
KR1020147009054A 2011-09-09 2012-09-07 카바페넴의 무세포 제조법 Withdrawn KR20150010932A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161533039P 2011-09-09 2011-09-09
US61/533,039 2011-09-09
PCT/US2012/054195 WO2013036787A2 (en) 2011-09-09 2012-09-07 Cell-free preparation of carbapenems

Publications (1)

Publication Number Publication Date
KR20150010932A true KR20150010932A (ko) 2015-01-29

Family

ID=46940589

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020147009054A Withdrawn KR20150010932A (ko) 2011-09-09 2012-09-07 카바페넴의 무세포 제조법

Country Status (9)

Country Link
US (2) US9469861B2 (enExample)
EP (1) EP2753702B1 (enExample)
JP (1) JP2014526250A (enExample)
KR (1) KR20150010932A (enExample)
CN (1) CN104093848A (enExample)
CA (1) CA2846893A1 (enExample)
IL (1) IL231010A0 (enExample)
SG (1) SG2014014377A (enExample)
WO (1) WO2013036787A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0811530B1 (pt) 2007-05-14 2019-01-02 Research Foundation Of State Univ Of New York composição compreendendo indutor(es) de resposta fisiológica à dispersão ácido decanóico, superfície, solução, método ex vivo de tratamento ou inibição da formação de um biofilme sobre uma superfície
US9637746B2 (en) 2008-12-15 2017-05-02 Greenlight Biosciences, Inc. Methods for control of flux in metabolic pathways
ES2718844T3 (es) 2010-05-07 2019-07-04 Greenlight Biosciences Inc Métodos para controlar el flujo en rutas metabólicas mediante la reubicación de enzimas
US8916358B2 (en) 2010-08-31 2014-12-23 Greenlight Biosciences, Inc. Methods for control of flux in metabolic pathways through protease manipulation
RU2015129774A (ru) 2012-12-21 2017-02-01 Гринлайт Байосайенсиз, Инк. Бесклеточная система для преобразования метана в топливо, пируват или изобутанол
JP6483687B2 (ja) 2013-08-05 2019-03-13 グリーンライト バイオサイエンシーズ インコーポレーテッドＧｒｅｅｎｌｉｇｈｔ Ｂｉｏｓｃｉｅｎｃｅｓ，Ｉｎｃ． プロテアーゼ切断部位を有する操作されたタンパク質
BR112017020690A2 (pt) 2015-03-30 2018-06-26 Greenlight Biosciences Inc produção livre de células de ácido ribonucleico
CN109196109B (zh) 2016-04-06 2024-06-25 绿光生物科技股份有限公司 无细胞生成核糖核酸
NL2017636B1 (en) 2016-10-18 2018-04-26 Univ Delft Tech Methods for increasing production of carbapenem antibiotics and derivatives in bacteria
AU2018205503A1 (en) 2017-01-06 2019-07-25 Greenlight Biosciences, Inc. Cell-free production of sugars
CN107630054A (zh) * 2017-04-13 2018-01-26 绍兴百茵生物技术有限公司 培南类药物中间体的生物转化方法
BR112020007068A2 (pt) 2017-10-11 2020-10-06 Greenlight Biosciences, Inc. métodos e composições para produção de nucleosídeo trifosfato e ácido ribonucleico
US11319320B2 (en) 2017-11-06 2022-05-03 Snap Bio, Inc. PIM kinase inhibitor compositions, methods, and uses thereof
NL2020614B1 (en) 2018-03-19 2019-09-30 Univ Delft Tech Method for producing cell wall-targeting antibiotics in susceptible bacteria

Family Cites Families (130)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE28886E (en) 1969-08-04 1976-06-29 Kyowa Hakko Kogyo Co., Ltd. Method for preparing cytidine diphosphate choline
JPS4841555B1 (enExample) 1969-08-04 1973-12-07
US4006060A (en) 1974-11-25 1977-02-01 Merck & Co., Inc. Thienamycin production
US3950357A (en) 1974-11-25 1976-04-13 Merck & Co., Inc. Antibiotics
US4194047A (en) 1975-11-21 1980-03-18 Merck & Co., Inc. Substituted N-methylene derivatives of thienamycin
US4266034A (en) 1978-04-14 1981-05-05 Exxon Research And Engineering Company Method for producing microbial cells and use thereof to produce oxidation products
US4248966A (en) 1979-05-17 1981-02-03 Massachusetts Institute Of Technology Synthesis of isopenicillin derivatives in the absence of living cells
US4270537A (en) 1979-11-19 1981-06-02 Romaine Richard A Automatic hypodermic syringe
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4329481A (en) 1980-06-25 1982-05-11 Merck & Co., Inc. Process for the preparation of N-protected N-formimidoyl 2-aminoethanethiol
US4292436A (en) 1980-06-25 1981-09-29 Merck & Co., Inc. Process for the preparation of N-protected N-formimidoyl 2-aminoethanethiol
US4374772A (en) 1981-03-19 1983-02-22 Merck & Co., Inc. Process for the preparation of N-formimidoyl thienamycin and reagents therefor
JPS585189A (ja) 1981-07-01 1983-01-12 Sanraku Inc 新規なアミドヒドロラ−ゼ
US4460689A (en) 1982-04-15 1984-07-17 Merck & Co., Inc. DNA Cloning vector TG1, derivatives, and processes of making
JPS617788A (ja) 1984-06-22 1986-01-14 Sony Corp 静止画記録再生装置
US4596556A (en) 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
EP0202094B1 (en) 1985-05-13 1988-09-21 Unitika Ltd. Process for producing physiologically active substance
JPS61260895A (ja) 1985-05-13 1986-11-19 Unitika Ltd 生理活性物質の製造方法
US5672497A (en) 1986-03-21 1997-09-30 Eli Lilly And Company Method for increasing the antibiotic-producing ability of antibiotic-producing microorganisms
US4886499A (en) 1986-12-18 1989-12-12 Hoffmann-La Roche Inc. Portable injection appliance
US4946783A (en) 1987-01-30 1990-08-07 President And Fellows Of Harvard College Periplasmic protease mutants of Escherichia coli
GB8704027D0 (en) 1987-02-20 1987-03-25 Owen Mumford Ltd Syringe needle combination
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US4941880A (en) 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
US4940460A (en) 1987-06-19 1990-07-10 Bioject, Inc. Patient-fillable and non-invasive hypodermic injection device assembly
US4950603A (en) 1987-11-02 1990-08-21 Eli Lilly And Company Recombinant DNA expression vectors and DNA compounds that encode isopenicillin N synthetase from Streptomyces lipmanii
JPH01228473A (ja) 1988-03-08 1989-09-12 Hikari Kimura 新規な組み換え体ｄｎａおよびグルタチオンの製造法
US5339163A (en) 1988-03-16 1994-08-16 Canon Kabushiki Kaisha Automatic exposure control device using plural image plane detection areas
US5070020A (en) 1988-05-09 1991-12-03 Eli Lilly And Company Recombinant dna expression vectors and dna compounds that encode deacetoxycephalosporin c synthetase
FR2638359A1 (fr) 1988-11-03 1990-05-04 Tino Dalto Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
CA2005649A1 (en) 1988-12-22 1990-06-22 Matthew B. Tobin Recombinant dna expression vectors and dna compounds that encode isopenicillin n epimerase (racemase) activity
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
IL97000A0 (en) 1990-01-26 1992-03-29 Lilly Co Eli Recombinant dna expression vectors and dna compounds that encode isopenicillin n epimerase activity
US5190521A (en) 1990-08-22 1993-03-02 Tecnol Medical Products, Inc. Apparatus and method for raising a skin wheal and anesthetizing skin
US5527288A (en) 1990-12-13 1996-06-18 Elan Medical Technologies Limited Intradermal drug delivery device and method for intradermal delivery of drugs
GB9118204D0 (en) 1991-08-23 1991-10-09 Weston Terence E Needle-less injector
SE9102652D0 (sv) 1991-09-13 1991-09-13 Kabi Pharmacia Ab Injection needle arrangement
KR0177841B1 (ko) 1992-01-30 1999-04-01 나까무라 간노스께 시티딘 디인산 콜린의 제조방법
US5328483A (en) 1992-02-27 1994-07-12 Jacoby Richard M Intradermal injection device with medication and needle guard
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
US5569189A (en) 1992-09-28 1996-10-29 Equidyne Systems, Inc. hypodermic jet injector
US5334144A (en) 1992-10-30 1994-08-02 Becton, Dickinson And Company Single use disposable needleless injector
US5319122A (en) 1992-11-12 1994-06-07 Merck & Co., Inc. Process for the preparation of benzylformimidate
EP0679189B1 (en) 1993-01-15 2003-06-04 Genetics Institute, LLC Cloning of enterokinase and method of use
US6746859B1 (en) 1993-01-15 2004-06-08 Genetics Institute, Llc Cloning of enterokinase and method of use
US5436131A (en) 1993-04-02 1995-07-25 Merck & Co., Inc. Color screening assay for identifying inhibitor resistant HIV protease mutants
WO1995024176A1 (en) 1994-03-07 1995-09-14 Bioject, Inc. Ampule filling device
US5466220A (en) 1994-03-08 1995-11-14 Bioject, Inc. Drug vial mixing and transfer device
KR0131166B1 (ko) 1994-05-04 1998-04-11 최차용 무세포시스템에서 단백질을 제조하는 방법
GB9410142D0 (en) * 1994-05-20 1994-07-06 Univ Warwick Carbapenems
US5599302A (en) 1995-01-09 1997-02-04 Medi-Ject Corporation Medical injection system and method, gas spring thereof and launching device using gas spring
JPH08196284A (ja) 1995-01-19 1996-08-06 Canon Inc 酵素反応素子およびその製造方法、酵素反応器ならびに酵素反応方法
US5730723A (en) 1995-10-10 1998-03-24 Visionary Medical Products Corporation, Inc. Gas pressured needle-less injection device and method
WO1997002358A1 (en) 1995-07-06 1997-01-23 The Leland Stanford Junior University Cell-free synthesis of polyketides
US6537776B1 (en) 1999-06-14 2003-03-25 Diversa Corporation Synthetic ligation reassembly in directed evolution
US5893397A (en) 1996-01-12 1999-04-13 Bioject Inc. Medication vial/syringe liquid-transfer apparatus
GB9607549D0 (en) 1996-04-11 1996-06-12 Weston Medical Ltd Spring-powered dispensing device
KR100205768B1 (en) 1996-08-24 1999-07-01 Choongwae Pharm Co Stereo-selective composition of 4-acetoxyazetidinone
GB9622516D0 (en) 1996-10-29 1997-01-08 Univ Cambridge Tech Enzymic cofactor cycling
US20020160459A1 (en) 1997-01-14 2002-10-31 Alan Berry Process for production of n-glucosamine
US5993412A (en) 1997-05-19 1999-11-30 Bioject, Inc. Injection apparatus
IT1298087B1 (it) 1998-01-08 1999-12-20 Fiderm S R L Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
GB9815666D0 (en) * 1998-07-17 1998-09-16 Smithkline Beecham Plc Novel compounds
US6613552B1 (en) 1999-01-29 2003-09-02 Board Of Trustees Operating Michigan State University Biocatalytic synthesis of shikimic acid
US6994986B2 (en) 1999-03-17 2006-02-07 The Board Of Trustees Of The Leland Stanford University In vitro synthesis of polypeptides by optimizing amino acid metabolism
CA2365668C (en) 1999-03-17 2014-05-20 The Board Of Trustees Of The Leland Stanford Junior University In vitro macromolecule biosynthesis methods using exogenous amino acids and a novel atp regeneration system
US6168931B1 (en) 1999-03-17 2001-01-02 The Board Of Trustees Of The Leland Stanford Junior University Enhanced in vitro synthesis of biological macromolecules using a novel ATP regeneration system
WO2000062804A2 (en) 1999-04-15 2000-10-26 The Regents Of The University Of California Identification of sortase gene
US6284483B1 (en) 1999-10-06 2001-09-04 Board Of Trustees Operating Michigan State University Modified synthetases to produce penicillins and cephalosporins under the control of bicarbonate
CA2293852A1 (fr) 1999-12-30 2001-06-30 Purecell Technologies Inc. Procede de preparation d'extraits de plantes actifs et utiles a la capture de radicaux libres; les extraits, et compositions et dispositifs les comprenant
US6548276B2 (en) 2000-09-06 2003-04-15 The Board Of Trustees Of The Leland Stanford Junior University Enhanced in vitro synthesis of active proteins containing disulfide bonds
US7041479B2 (en) 2000-09-06 2006-05-09 The Board Of Trustess Of The Leland Stanford Junior University Enhanced in vitro synthesis of active proteins containing disulfide bonds
KR20080113283A (ko) 2001-04-04 2008-12-29 제넨코 인터내셔날 인코포레이티드 숙주 세포에서의 생산물의 생산 방법
WO2002088325A2 (en) 2001-05-02 2002-11-07 University Of South Florida Vector system for selection of genes encoding secreted proteins and membrane-bound proteins
RU2294370C2 (ru) 2001-09-06 2007-02-27 Адзиномото Ко., Инк. Способ получения спирта с использованием микроорганизма
AU2002326884B2 (en) 2001-09-13 2007-10-18 Genentech, Inc. Aminopeptidase
AU2002363144A1 (en) 2001-10-30 2003-05-12 The Board Of Trustees Of The Leland Stanford Junior University Enhanced in vitro nucleic acid synthesis using nucleoside monophosphates
US20040038250A1 (en) 2002-04-04 2004-02-26 Astur-Pharma, S.A. Gene cluster for thienamycin biosynthesis, genetic manipulation and utility
DE10219714A1 (de) 2002-05-02 2003-11-27 Holland Sweetener Co Verfahren zur mikrobielien Herstellung von aromatischen Aminosäuren und anderen Metaboliten des aromatischen Aminosäurebiosyntheseweges
US20050164359A1 (en) 2002-05-08 2005-07-28 Hashimoto Shin-Ichi Process for producing cytidine 5'-diphosphate choline
MXPA04012978A (es) 2002-07-01 2005-09-12 Arkion Life Sciences Llc D B A Proceso y material para la produccion de glucosamina y n-acetilglucosamina.
CA2496437C (en) 2002-08-19 2013-01-08 The Board Of Trustees Of The Leland Stanford Junior University Improved methods of in vitro protein synthesis
US7223390B2 (en) 2003-05-09 2007-05-29 Research Development Foundation Insertion of furin protease cleavage sites in membrane proteins and uses thereof
US7341852B2 (en) 2003-07-18 2008-03-11 The Board Of Trustees Of The Leland Stanford Junior University Methods of decoupling reaction scale and protein synthesis yield in batch mode
US20050054044A1 (en) 2003-07-18 2005-03-10 The Board Of Trustees Of The Leland Stanford Junior University Method of alleviating nucleotide limitations for in vitro protein synthesis
WO2005030949A1 (en) 2003-09-24 2005-04-07 Board Of Trustees Operating Michigan State University Methods and materials for the production of shikimic acid
CN101014716B (zh) 2003-11-20 2015-06-10 小利兰·斯坦福大学托管委员会 体外蛋白质合成的改进方法
EA010837B1 (ru) 2004-03-25 2008-12-30 Зе Боард Оф Трастиз Оф Зе Лилэнд Стэнфорд Джуниор Юниверсити Повышение выхода экспрессии протеина в системах бесклеточного синтеза протеинов путём добавления антипенных присадок
US8257943B2 (en) 2004-06-25 2012-09-04 Kyowa Hakko Bio Co., Ltd. Process for producing dipeptides or dipeptide derivatives
EP1819813A2 (en) 2004-12-10 2007-08-22 DSMIP Assets B.V. Production of beta-lactam antibiotics by genetically modified non-naturally producing microorganisms
WO2006090385A2 (en) 2005-02-22 2006-08-31 Ramot At Tel-Aviv University Ltd. Protease inhibitors and method of screening thereof
US7351563B2 (en) 2005-06-10 2008-04-01 The Board Of Trustees Of The Leland Stanford Junior University Cell-free extracts and synthesis of active hydrogenase
US7312049B2 (en) 2005-06-14 2007-12-25 The Board Of Trustees Of The Leland Stanford Junior University Total amino acid stabilization during cell-free protein synthesis
TW200741005A (en) 2005-08-10 2007-11-01 Kyowa Hakko Kogyo Kk A purification method of cytidine diphosphate
US7517680B2 (en) 2005-09-09 2009-04-14 Johns Hopkins University Production of clavulanic acid by genetic engineering of Streptomyces clavuligerus
US8183010B2 (en) 2005-10-31 2012-05-22 The Board Of Trustees Of The Leland Stanford Junior University Cell-free synthesis of membrane bound polypeptides
WO2007137144A2 (en) 2006-05-17 2007-11-29 University Of Medicine And Dentistry Of New Jersey Single protein production in living cells facilitated by a messenger rna interferase
WO2007140816A1 (en) 2006-06-09 2007-12-13 Metabolic Explorer Glycolic acid production by fermentation from renewable resources
WO2007144018A1 (en) 2006-06-12 2007-12-21 Metabolic Explorer Ethanolamine production by fermentation
US20110129438A1 (en) 2006-06-28 2011-06-02 James Robert Swartz Immunogenic protein constructs
WO2008002661A2 (en) 2006-06-28 2008-01-03 The Board Of Trustees Of The Leland Stanford Junior University Fusion protein constructs
AU2007325952B8 (en) 2006-06-29 2013-06-27 The Board Of Trustees Of The Leland Stanford Junior University Cell-free synthesis of proteins containing unnatural amino acids
WO2008002673A2 (en) 2006-06-29 2008-01-03 The Board Of Trustees Of The Leland Stanford Junior University Cell-free synthesis of virus like particles
US8293894B2 (en) 2006-11-20 2012-10-23 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of carbapenem antibiotic
KR100832740B1 (ko) 2007-01-17 2008-05-27 한국과학기술원 분지쇄 아미노산 생성능이 개선된 변이 미생물 및 이를이용한 분지쇄 아미노산의 제조방법
US7871794B2 (en) 2007-01-18 2011-01-18 The Board Of Trustees Of The Leland Stanford Junior University Enhanced cell-free synthesis of active proteins containing disulfide bonds
WO2008094546A2 (en) 2007-01-31 2008-08-07 The Regents Of The University Of California Genetically modified host cells for increased p450 activity levels and methods of use thereof
US20090124012A1 (en) 2007-08-08 2009-05-14 Mazef Biosciences, Llc Toxin/antitoxin systems and methods for regulating cellular growth, metabolic engineering and production of recombinant proteins
EP2242842A1 (en) 2008-02-14 2010-10-27 Wageningen Universiteit Nucleotide sequences coding for cis-aconitic decarboxylase and use thereof
SI2262901T1 (sl) 2008-03-05 2019-02-28 Genomatica, Inc. Primarni alkohol producirajoči organizmi
JP2011519561A (ja) 2008-05-01 2011-07-14 ジェノマティカ， インコーポレイテッド メタクリル酸の産生のための微生物
JP5750370B2 (ja) 2008-07-28 2015-07-22 ブレイン・バイオテクノロジー・リサーチ・アンド・インフォメーション・ネットワーク・アクチェンゲゼルシャフト 生産方法
GB0819563D0 (en) 2008-10-24 2008-12-03 Isis Innovation Methods for preparing heterocyclic rings
BRPI0914521A2 (pt) 2008-10-27 2016-07-26 Butamax Advanced Biofuels Llc célula hospedeira microbiana recombinante, método de aumento da produção de isobutanol e método de produção de isobutanol
WO2010051527A2 (en) 2008-10-31 2010-05-06 Gevo, Inc. Engineered microorganisms capable of producing target compounds under anaerobic conditions
US9637746B2 (en) 2008-12-15 2017-05-02 Greenlight Biosciences, Inc. Methods for control of flux in metabolic pathways
CN105132387A (zh) * 2008-12-22 2015-12-09 绿光生物科学公司 用于制造化合物的组合物和方法
EP2204453B1 (en) 2008-12-30 2013-03-13 Süd-Chemie IP GmbH & Co. KG Process for cell-free production of chemicals
US8597923B2 (en) 2009-05-06 2013-12-03 SyntheZyme, LLC Oxidation of compounds using genetically modified Candida
WO2010141468A1 (en) 2009-06-01 2010-12-09 Way Jeffrey C Methods and molecules for yield improvement involving metabolic engineering
EP2462221B1 (en) 2009-08-05 2017-02-22 Genomatica, Inc. Semi-synthetic terephthalic acid via microorganisms that produce muconic acid
EP2513112A4 (en) 2009-12-11 2013-05-08 Univ Johns Hopkins PROCEDURE FOR LATE ADDITION OF THE (8R) -HYDROXYL GROUP TO THE CARBAPENEM BETA-LACTAM ANTIBIOTICASYNTHESIS
US9040253B2 (en) 2010-04-14 2015-05-26 Sutro Biopharma, Inc. Method for enhancing recombinant protein production by cell-free protein expression system
ES2718844T3 (es) 2010-05-07 2019-07-04 Greenlight Biosciences Inc Métodos para controlar el flujo en rutas metabólicas mediante la reubicación de enzimas
US8916358B2 (en) * 2010-08-31 2014-12-23 Greenlight Biosciences, Inc. Methods for control of flux in metabolic pathways through protease manipulation
WO2012135902A1 (en) 2011-04-08 2012-10-11 James Cook University Protease activity assay
RU2015129774A (ru) 2012-12-21 2017-02-01 Гринлайт Байосайенсиз, Инк. Бесклеточная система для преобразования метана в топливо, пируват или изобутанол
AU2014274932A1 (en) 2013-06-05 2015-12-17 Greenlight Biosciences, Inc. Control of metabolic flux in cell-free biosynthetic systems
JP6483687B2 (ja) 2013-08-05 2019-03-13 グリーンライト バイオサイエンシーズ インコーポレーテッドＧｒｅｅｎｌｉｇｈｔ Ｂｉｏｓｃｉｅｎｃｅｓ，Ｉｎｃ． プロテアーゼ切断部位を有する操作されたタンパク質

Also Published As

Publication number Publication date
EP2753702B1 (en) 2021-12-15
US9469861B2 (en) 2016-10-18
IL231010A0 (en) 2014-03-31
JP2014526250A (ja) 2014-10-06
SG2014014377A (en) 2014-05-29
CN104093848A (zh) 2014-10-08
HK1199909A1 (en) 2015-07-24
EP2753702A2 (en) 2014-07-16
US20170096692A1 (en) 2017-04-06
US20130065878A1 (en) 2013-03-14
WO2013036787A2 (en) 2013-03-14
CA2846893A1 (en) 2013-03-14
WO2013036787A3 (en) 2013-06-13

Similar Documents

Publication Publication Date Title
KR20150010932A (ko) 카바페넴의 무세포 제조법
CN103555782B (zh) 生产莫纳甜和莫纳甜前体
EP2612913B1 (en) Novel hydrolase protein
CA2606178A1 (en) Polypeptides and biosynthetic pathways for the production of monatin and its precursors
KR102108021B1 (ko) 글루타릭산 생산용 재조합 코리네박테리움 글루타미컴 균주 및 이를 이용한 글루타릭산 생산 방법
EP2202294A1 (en) Bacterial cells having a glyoxylate shunt for the manufacture of succinic acid
EP2451955B1 (en) Process for preparation of tacrolimus
EP2204443A1 (en) Bacterial cells exhibiting formate dehydrogenase activity for the manufacture of suc-cinic acid
KR20220158770A (ko) 칸나비노이드 및 칸나비노이드 전구체의 생합성
US20150056675A1 (en) Hydrocarbon synthase gene and use thereof
US7923231B2 (en) Production of glucuronic acid using myo-inositol oxygenase from cryptococcus neoformans
CN108300743B (zh) 一种(r)-2-氯-1-(6-氟-苯并二氢吡喃-2-基)-1-乙醇的生物催化方法
EP1576159B9 (en) The gene cluster involved in safracin biosynthesis and its uses for genetic engineering
JP2019504650A (ja) プロセス
HK1199909B (en) Cell-free preparation of carbapenems
BR112016018162B1 (pt) Micro-organismo modificado, método para produzir um composto orgânico e uso de um micro-organismo modificado
CN115093977B (zh) 产富马酸的普鲁兰短梗霉菌株ep01及使用方法
US20250276031A1 (en) Prodrugs as selective antibiotics against colibactin-producing e. coli
CN1685051A (zh) 生产维生素b6的重组微生物
La et al. Effects of glycerol and shikimic acid on rapamycin production in Streptomyces rapamycinicus
US7977077B2 (en) Synthesis of intermediates of oseltamivir carboxylates
WO2015145152A1 (en) Antimicrobial agents
Wessely BIOSYNTHETIC AND REGULATORY INSIGHTS INTO DYNEMICIN A PRODUCTION
Wong Divergent evolution of enzymes in the crotonase superfamily: Exploring functional diversity and challenging mechanistic paradigms
Philmus Investigations into the microcystin gene cluster from Hapalosiphon hibernicus BZ-3-1 and Planktothrix agardhii CYA 126/8

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20140404

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid